The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancer (original) (raw)

Challenges in prescribing drugs for children with cancer

K. Pritchard-jones, Paolo Paolucci

The Lancet Oncology, 2008

View PDFchevron_right

Chemotherapy-related side effects in childhood cancer in Hiwa Hospital Sulaimani city

Awayi Abdulkareem

View PDFchevron_right

PhD thesis DIAGNOSTIC, THERAPEUTIC AND BIOCHEMICAL ASPECTS OF CHILDHOOD CANCER MANAGEMENT

Katalin Bartyik

2007

View PDFchevron_right

Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline

Andrea Orsey

Pediatric Blood & Cancer

View PDFchevron_right

Chemotherapy Associated Side Effects among Children with Cancer

Emon Chanu

International Journal of Health Sciences and Research, 2021

View PDFchevron_right

The role of the ‘innovative therapies for children with cancer’ (ITCC) European consortium

Riccardo Riccardi

Cancer Treatment Reviews, 2010

View PDFchevron_right

An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children

David Walker

Archives of Disease in Childhood, 1996

View PDFchevron_right

Clinical Trials in Paediatric Oncology

R. Serreau

Thérapie, 2003

View PDFchevron_right

Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors

Anna Meadows

Pediatric Blood & Cancer, 2013

View PDFchevron_right

Progress in the Curative Treatment of Childhood Hematologic Malignancies

Gregory Reaman

JNCI Journal of the National Cancer Institute, 2008

View PDFchevron_right

Challenging issues in pediatric oncology

Amar Gajjar

Nature Reviews Clinical Oncology, 2011

View PDFchevron_right

Home chemotherapy for children with cancer

Oya Tugal

Cancer, 1992

View PDFchevron_right

Acute arrhythmogenicity of first-dose chemotherapeutic agents in children

Philippe Lepage

Medical and Pediatric Oncology, 2002

View PDFchevron_right

Use of unconventional medicine in children with cancer

Elaine Alves

2000

View PDFchevron_right

Referential study of a chemotherapy protocol for acute lymphocytic leukemia in childhood

Denise Bueno

2010

View PDFchevron_right

Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica

Roberto Miniero

Haematologica, 1998

View PDFchevron_right

Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

Archie Bleyer

Medical and Pediatric Oncology, 1991

View PDFchevron_right

The process of drug development in pediatric oncology: a review of basic principals and a look into the future

Gilberto Schwartsmann

Clinical Investigation, 2011

View PDFchevron_right

Delayed Consequences of Therapy For Childhood Cancer

Anna Meadows

CA: A Cancer Journal for Clinicians, 1985

View PDFchevron_right

Anterior Intratumoural Chemotherapy: A Newer Modality of Treatment in Advanced Solid Tumours in Children

Vijayendra Kumar

Asian Journal of Surgery, 2008

View PDFchevron_right

A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity and preliminary results

Robert Chilcote

Medical and Pediatric Oncology, 1980

View PDFchevron_right

Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients

Mark Holdsworth

Pediatric Blood & Cancer, 2011

View PDFchevron_right

Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium

Lucas Moreno

European journal of cancer (Oxford, England : 1990), 2017

View PDFchevron_right

Outcome in pediatric acute lymphoblastic leukemia in children and adolescents using contemporary protocols of chemotherapy – experience of a single Pediatric Hematology-Oncology Center

Mihaela Dragomir

Romanian Journal of Medical Practice, 2015

View PDFchevron_right

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group

Meenakshi Devidas, Naomi Winick

Leukemia, 2010

View PDFchevron_right

Metronomic Chemotherapy as a New Strategy for End-stage Pediatric Oncology Patients in Iran

babak abdolkarimi

The Middle East Journal

View PDFchevron_right

Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study group

Ira Bernstein

Medical and Pediatric Oncology, 1979

View PDFchevron_right

Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia

Joanna Zawitkowska

In Vivo

View PDFchevron_right

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients

Mark Holdsworth

Pediatric Blood & Cancer, 2013

View PDFchevron_right